Synerk is a leading biomedical company dedicated to the research and development of new small nucleic acid drugs and clinical research. Synerk Pharmaceutical Technology (Suzhou) Co., Ltd. was established in 2021, and a global R & D center was established in Suzhou Biopharmaceutical Park, as well as an independent R & D center in Beijing.

The core technical team has many years of experience in RNA targeted therapy industry and proprietary medicine experience. The company team is committed to building a world-leading biomedical company integrating R & D, clinical, production and sales in the field of RNA therapy.

About Us